2024-10-07 - Analysis Report
## Thermo Fisher Scientific Inc (TMO) Stock Analysis:

**1. Performance Comparison:**

Thermo Fisher Scientific Inc (TMO) is a global leader in providing laboratory instruments, consumables, and services to the life sciences, healthcare, and industrial markets. 

TMO has significantly outperformed the S&P 500 (VOO) over the period analyzed. The cumulative return of TMO is 242.04%, compared to 133.14% for the S&P 500. This represents a difference of **108.9%**, which places TMO at **50.35%** relative to the maximum historical deviation from the S&P 500. 

**2. Recent Price Action:**

* **Closing Price:** $598.61
* **5-Day Moving Average:** $608.75
* **20-Day Moving Average:** $612.93
* **60-Day Moving Average:** $600.22

The stock is currently trading below its 5-day and 20-day moving averages, suggesting potential short-term downward pressure. However, the 60-day moving average indicates a longer-term upward trend. 

**3. Technical Indicators:**

* **RSI:** 39.59. The RSI is currently in the oversold territory, suggesting that the stock may be due for a rebound.
* **PPO:** -0.35. The PPO is negative, indicating potential bearish momentum.
* **Delta_Previous_Relative_Divergence:** -9.42. This signifies a recent decrease in relative performance compared to the S&P 500. 
* **Expected Return:** 11.29%. The expected return represents a potential 5-year outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The company's most recent earnings report on August 2nd, 2024, saw a significant increase in EPS (4.05) compared to the previous quarter (3.47). While revenue remained relatively stable, the strong earnings growth reflects a positive outlook for the company. It is important to consider the analysts' forecasts and potential future earnings announcements to better assess the company's performance.

**5. News and Recent Issues:**

* **Recent Market Outlook:** The current market outlook for TMO is generally positive, with analysts citing the company's robust growth in its life sciences segment and the ongoing demand for laboratory equipment and consumables.
* **Analyst Opinions:** The majority of analysts have a "Buy" or "Strong Buy" rating on TMO. 
* **Performance Highlights:** Recent news highlights the company's strong performance, including the acquisition of a leading manufacturer of bioprocessing equipment and its continued expansion into new markets.

**6. Overall Analysis:**

TMO exhibits a strong long-term performance, significantly outperforming the S&P 500. Recent price action suggests potential short-term weakness, but the long-term trend remains positive. Technical indicators indicate a possible rebound, and the recent earnings report suggests a strong financial outlook. However, it is important to monitor the market and analysts' recommendations to gain a comprehensive picture.

**7. Report in English:**

## Thermo Fisher Scientific Inc (TMO) Stock Analysis:

**1. Performance Comparison:**

Thermo Fisher Scientific Inc (TMO) is a global leader in providing laboratory instruments, consumables, and services to the life sciences, healthcare, and industrial markets. 

TMO has significantly outperformed the S&P 500 (VOO) over the period analyzed. The cumulative return of TMO is 242.04%, compared to 133.14% for the S&P 500. This represents a difference of **108.9%**, which places TMO at **50.35%** relative to the maximum historical deviation from the S&P 500. 

**2. Recent Price Action:**

* **Closing Price:** $598.61
* **5-Day Moving Average:** $608.75
* **20-Day Moving Average:** $612.93
* **60-Day Moving Average:** $600.22

The stock is currently trading below its 5-day and 20-day moving averages, suggesting potential short-term downward pressure. However, the 60-day moving average indicates a longer-term upward trend. 

**3. Technical Indicators:**

* **RSI:** 39.59. The RSI is currently in the oversold territory, suggesting that the stock may be due for a rebound.
* **PPO:** -0.35. The PPO is negative, indicating potential bearish momentum.
* **Delta_Previous_Relative_Divergence:** -9.42. This signifies a recent decrease in relative performance compared to the S&P 500. 
* **Expected Return:** 11.29%. The expected return represents a potential 5-year outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The company's most recent earnings report on August 2nd, 2024, saw a significant increase in EPS (4.05) compared to the previous quarter (3.47). While revenue remained relatively stable, the strong earnings growth reflects a positive outlook for the company. It is important to consider the analysts' forecasts and potential future earnings announcements to better assess the company's performance.

**5. News and Recent Issues:**

* **Recent Market Outlook:** The current market outlook for TMO is generally positive, with analysts citing the company's robust growth in its life sciences segment and the ongoing demand for laboratory equipment and consumables.
* **Analyst Opinions:** The majority of analysts have a "Buy" or "Strong Buy" rating on TMO. 
* **Performance Highlights:** Recent news highlights the company's strong performance, including the acquisition of a leading manufacturer of bioprocessing equipment and its continued expansion into new markets.

**6. Overall Analysis:**

TMO exhibits a strong long-term performance, significantly outperforming the S&P 500. Recent price action suggests potential short-term weakness, but the long-term trend remains positive. Technical indicators indicate a possible rebound, and the recent earnings report suggests a strong financial outlook. However, it is important to monitor the market and analysts' recommendations to gain a comprehensive picture.